A smart secure virtual reality immersive application for alzheimer’s and dementia patients

A smart secure virtual reality immersive application for alzheimer’s and dementia patients

Our proposed solution is a system integrates VR, voice recognition, and AI to provide smart and…

Continue Reading
Donanemab licensed for early stages of Alzheimer’s disease in adult patients who have one or no copies of apolipoprotein E4 gene

Donanemab licensed for early stages of Alzheimer’s disease in adult patients who have one or no copies of apolipoprotein E4 gene

Donanemab works by removing a sticky protein called beta-amyloid from the brain that is believed to…

Continue Reading
GE Healthcare wins FDA clearance for Alzheimer’s imaging software

GE Healthcare wins FDA clearance for Alzheimer’s imaging software

Dive Brief: GE Healthcare has received 510(k) clearance for a tool designed to help clinicians assess…

Continue Reading
GE HealthCare’s Brain Imaging Tool For Alzheimer’s Wins FDA Nod

GE HealthCare’s Brain Imaging Tool For Alzheimer’s Wins FDA Nod

GE HealthCare’s MIM Software has received U.S. Food and Drug Administration (FDA) 510(k) clearance for Centiloid…

Continue Reading
Direct healthcare expenditure on Alzheimer’s disease from healthcare providers’ perspective in Malaysia: a micro-costing approach

Direct healthcare expenditure on Alzheimer’s disease from healthcare providers’ perspective in Malaysia: a micro-costing approach

American Psychiatric Association D, Association AP. Diagnostic and Statistical Manual of Mental Disorders: DSM-5 (American Psychiatric…

Continue Reading